← European Medicine Shortage Tracker · all medicines

Telmisartan shortage — availability across Europe

Name: European Medicine Shortage Tracker dataset
Creator: MobiDoctor
License: https://creativecommons.org/licenses/by/4.0/

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Telmisartan currently has availability issues reported in 2 European registers: Spain, Italy.

Shortage ATC — · also listed as: TELMISARTAN · data refreshed 5 November 2026

Key facts

As of 5 November 2026, Telmisartan has active availability issues in 2 of 10 tracked European registers.
Registers reporting issues: Spain, Italy.
Latest expected-resolution date on file: 2027-02-22.
Longest-running open report: since 2022-12-12 (47 months, Italy).
Data source: 2 official medicines-agency registers, refreshed daily.

As of 5 November 2026, 2 of the 10 tracked registers list current availability issues for Telmisartan, covering 12 affected product presentations. The longest-running open report was filed in Italy on 2022-12-12 and has now been open for about 47 months. Where agencies state a cause, manufacturing problems lead with 5 of the 8 stated-cause reports, followed by commercial decisions or discontinuation with 2. The furthest expected-resolution date currently on file is 2027-02-22; the earliest is 2026-12-09. Momentum is current, not historical: 5 of the open reports were filed within the last 90 days. Registers in Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇪🇸 Spain	Shortage TELMISARTAN KERN PHARMA 40 MG COMPRIMIDOS EFG , 28 comprimidos + 3 more products TELMISARTAN KERN PHARMA 80 MG COMPRIMIDOS EFG , 28 comprimidos TELMISARTAN VIATRIS 40 MG COMPRIMIDOS EFG, 28 comprimidos TELMISARTAN VIATRIS 80 MG COMPRIMIDOS EFG, 28 comprimidos	2026-02-26	2027-02-22	Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.	register ↗
🇮🇹 Italy	Shortage TELMISARTAN AUROBINDO + 7 more products TELMISARTAN AUROBINDO TELMISARTAN MYLAN TELMISARTAN MYLAN TELMISARTAN MYLAN TELMISARTAN PENSA TELMISARTAN PENSA TELMISARTAN ZENTIVA	2022-12-12	—	Elevata richiesta/problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available.	register ↗

New register reports per month

Full report history (12 register entries)

Every individual register entry for Telmisartan in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇮🇹 IT	TELMISARTAN PENSA	Shortage	2026-12-15	—	Cessata commercializzazione definitiva
🇮🇹 IT	TELMISARTAN AUROBINDO	Shortage	2026-11-22	—	Elevata richiesta/problemi produttivi
🇮🇹 IT	TELMISARTAN PENSA	Shortage	2026-11-16	—	Cessata commercializzazione definitiva
🇮🇹 IT	TELMISARTAN MYLAN	Shortage	2026-09-21	—	Problemi produttivi
🇮🇹 IT	TELMISARTAN AUROBINDO	Shortage	2026-09-03	—	Problemi produttivi
🇪🇸 ES	TELMISARTAN KERN PHARMA 40 MG COMPRIMIDOS EFG , 28 comprimidos	Shortage	2026-07-29	2026-12-09	Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ES	TELMISARTAN VIATRIS 40 MG COMPRIMIDOS EFG, 28 comprimidos	Shortage	2026-06-23	2027-02-15	Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ES	TELMISARTAN VIATRIS 80 MG COMPRIMIDOS EFG, 28 comprimidos	Shortage	2026-06-17	2027-02-22	Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ES	TELMISARTAN KERN PHARMA 80 MG COMPRIMIDOS EFG , 28 comprimidos	Shortage	2026-02-26	—	Existen otros medicamentos con el mismo principio activo y m
🇮🇹 IT	TELMISARTAN MYLAN	Shortage	2025-11-05	—	Problemi produttivi
🇮🇹 IT	TELMISARTAN MYLAN	Shortage	2025-07-28	—	Elevata richiesta
🇮🇹 IT	TELMISARTAN ZENTIVA	Shortage	2022-12-12	—	Problemi produttivi

Frequently asked

Is Telmisartan currently in shortage in Europe?

Yes. As of 5 November 2026, availability issues are reported in: Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Telmisartan shortage expected to end?

Agency prognoses on file range from 2026-12-09 to 2027-02-22. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Telmisartan?

12 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Telmisartan availability data come from?

Directly from the official medicines-agency registers that list Telmisartan: AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Telmisartan — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/telmisartan/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Telmisartan availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/telmisartan/">Telmisartan shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Telmisartan: availability status across 2 European registers — European Medicine Shortage Tracker (MobiDoctor), 5 November 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.